Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Riordan

Showing results (71-80 of 99) with videos related to

Pageof 10
Sort By:
Journal of Hematology & Oncology|December 8, 2021
WDR26 and MTF2 are therapeutic targets in multiple myelomaFumou Sun, Yan Cheng, Jesse D Riordan, et al.
Puerto Rico Health Sciences Journal|September 21, 2004
Cell membrane fatty acid composition differs between normal and malignant cell linesXialong Meng, Neil H Riordan, Hugh D Riordan, et al.
RNA (New York, N.Y.)|October 13, 2018
Apobec1 complementation factor (A1CF) and RBM47 interact in tissue-specific regulation of C to U RNA editing in mouse intestine and liverValerie Blanc, Yan Xie, Susan Kennedy, et al.
BMJ Open Respiratory Research|November 2, 2019
Prevalence and outcome of central airway obstruction in patients with lung cancerCyrus Daneshvar, William Euan Falconer, Mohammed Ahmed, et al.
Integrative Cancer Therapies|February 8, 2005
Orthomolecular oncology review: ascorbic acid and cancer 25 years laterMichael J González, Jorge R Miranda-Massari, Edna M Mora, et al.
Gynecologic Oncology|December 6, 2025
Co-targeting the PI3K-Akt pathway improves response to MEK inhibition in low-grade serous ovarian cancer cell linesRebekah M Peplinski, Jesse D Riordan, Jacob L Schillo, et al.
Puerto Rico Health Sciences Journal|September 21, 2004
Intravenous vitamin C as a chemotherapy agent: a report on clinical casesHugh D Riordan, Neil H Riordan, James A Jackson, et al.
Hepatology (Baltimore, Md.)|September 30, 2017
Chronic liver injury alters driver mutation profiles in hepatocellular carcinoma in miceJesse D Riordan, Charlotte R Feddersen, Barbara R Tschida, et al.
Puerto Rico Health Sciences Journal|May 17, 2002
Orthomolecular oncology: a mechanistic view of intravenous ascorbate's chemotherapeutic activityMichael J González, Jorge R Miranda-Massari, Edna M Mora, et al.
Clinical Genetics|May 29, 2009
Cytogenetic microarrays in Manitoba patients with developmental delayA J Dawson, D Riordan, M Tomiuk, et al.
Pageof 10

Showing results (71-80 of 99) with videos related to

Sort By:
Pageof 10
Journal of Hematology & Oncology|December 8, 2021
WDR26 and MTF2 are therapeutic targets in multiple myelomaFumou Sun, Yan Cheng, Jesse D Riordan, et al.
Puerto Rico Health Sciences Journal|September 21, 2004
Cell membrane fatty acid composition differs between normal and malignant cell linesXialong Meng, Neil H Riordan, Hugh D Riordan, et al.
RNA (New York, N.Y.)|October 13, 2018
Apobec1 complementation factor (A1CF) and RBM47 interact in tissue-specific regulation of C to U RNA editing in mouse intestine and liverValerie Blanc, Yan Xie, Susan Kennedy, et al.
BMJ Open Respiratory Research|November 2, 2019
Prevalence and outcome of central airway obstruction in patients with lung cancerCyrus Daneshvar, William Euan Falconer, Mohammed Ahmed, et al.
Integrative Cancer Therapies|February 8, 2005
Orthomolecular oncology review: ascorbic acid and cancer 25 years laterMichael J González, Jorge R Miranda-Massari, Edna M Mora, et al.
Gynecologic Oncology|December 6, 2025
Co-targeting the PI3K-Akt pathway improves response to MEK inhibition in low-grade serous ovarian cancer cell linesRebekah M Peplinski, Jesse D Riordan, Jacob L Schillo, et al.
Puerto Rico Health Sciences Journal|September 21, 2004
Intravenous vitamin C as a chemotherapy agent: a report on clinical casesHugh D Riordan, Neil H Riordan, James A Jackson, et al.
Hepatology (Baltimore, Md.)|September 30, 2017
Chronic liver injury alters driver mutation profiles in hepatocellular carcinoma in miceJesse D Riordan, Charlotte R Feddersen, Barbara R Tschida, et al.
Puerto Rico Health Sciences Journal|May 17, 2002
Orthomolecular oncology: a mechanistic view of intravenous ascorbate's chemotherapeutic activityMichael J González, Jorge R Miranda-Massari, Edna M Mora, et al.
Clinical Genetics|May 29, 2009
Cytogenetic microarrays in Manitoba patients with developmental delayA J Dawson, D Riordan, M Tomiuk, et al.
Pageof 10